| Literature DB >> 34063863 |
Matteo Bolcato1, Daniele Rodriguez1, Alessandro Feola2, Giulio Di Mizio3, Alessandro Bonsignore4, Rosagemma Ciliberti5, Camilla Tettamanti4, Marco Trabucco Aurilio6, Anna Aprile1.
Abstract
The COVID-19 pandemic has evidenced the chronic inequality that exists between populations and communities as regards global healthcare. Vaccination, an appropriate tool for the prevention of infection, should be guaranteed by means of proportionate interventions to defeat such inequality in populations and communities affected by a higher risk of infection. Equitable criteria of justice should be identified and applied with respect to access to vaccination and to the order in which it should be administered. This article analyzes, as regards the worldwide distribution of anti-COVID-19 vaccines, the various ways the principle of equity has been construed and applied or even overlooked. The main obstacle to equal access to vaccines is vaccine nationalism. The perception of equity varies with the differing reference values adopted. Adequate response to needs appears to be the principal rule for achieving the criterion of equity in line with distributive justice. Priorities must be set equitably based on rational parameters in accordance with current needs. The entire process must be governed by transparency, from parameter identification to implementation. The issue of equal access to vaccination affects the entire world population, necessitating specific protective interventions. In light of this, the World Health Organization (WHO) has devised the COVAX plan to ensure that even the poorest nations of the world receive the vaccine; certain initiatives are also supported by the European Union (EU). This pandemic has brought to the fore the need to build a culture of equitable relationships both in each country's own domain and with the rest of the world.Entities:
Keywords: COVAX; COVID-19; equity; public health; vaccination
Year: 2021 PMID: 34063863 DOI: 10.3390/vaccines9060538
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X